Use of ginseng oligosaccharide and composition thereof in preparation of products for preventing, delaying or treating vascular depression
By using Morinda officinalis oligosaccharides and their combinations to regulate neurotransmitters and promote synaptic remodeling, the limitations of existing drugs for treating vascular depression and their significant side effects have been addressed, achieving a safe and effective neuroprotective effect.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING TONGRENTANG CO LTD
- Filing Date
- 2026-03-11
- Publication Date
- 2026-07-17
AI Technical Summary
Existing medications for treating vascular depression have limited efficacy, significant side effects, high costs, and inconvenience of use. Current physical and psychological treatments cannot fundamentally address the depressive symptoms caused by cerebrovascular lesions and neuronal damage.
Morinda officinalis oligosaccharides and their combinations are used as novel neuroprotective drugs. Through multi-target mechanisms such as regulating neurotransmitters, protecting mitochondria, inhibiting inflammation, and promoting synaptic remodeling, they are prepared into suitable dosage forms such as oral preparations, injections, and transdermal patches for administration.
It significantly improves symptoms of vascular depression, lowers blood pressure, reduces pathological damage to brain tissue, restores neurotransmitter levels, has few side effects, improves patient compliance, and provides continuous and effective treatment.
Smart Images
Figure CN122398823A_ABST